Journey Medical (NASDAQ: DERM) experienced a significant decline in after-hours trading on Tuesday, August 12, 2025, with shares dropping 16.63% to $7.12.
This movement followed the company’s Q2 2025 financial disclosure, where although revenue saw a slight increase of 1.01% year-over-year to $15.01 million, earnings disappointed with a loss of $0.16 per share, worse than the anticipated $0.10 per share loss.
This result contrasts with the day’s closing price of $8.54 and a trading volume of 980.10 thousand shares.
